Skip to main content
STADA Arzneimittel AG logo

STADA Arzneimittel AG — Investor Relations & Filings

Ticker · SAZ ISIN · DE0007251803 LEI · 529900FMTTLMH0P0DL10 HM Manufacturing
Open in API
Filings indexed 916 across all filing types
Latest filing 2022-08-17 Report Publication Anno…
Country DE Germany
Listing HM SAZ

About STADA Arzneimittel AG

https://www.stada.com/

STADA Arzneimittel AG is a pharmaceutical company that operates on a three-pillar strategy consisting of generics, consumer healthcare products, and specialty pharmaceuticals. The company is a leading manufacturer of affordable generic medicines, which have been a core part of its business since its founding. In the consumer healthcare segment, STADA markets a wide portfolio of over-the-counter (OTC) products and well-known brands. The specialty pharmaceuticals division focuses on developing and marketing value-added medicines, including an expanding portfolio of biosimilars for therapeutic areas such as oncology, immunology, and bone health.

Recent filings

Filing Released Lang Actions
Hinweis auf Halbjahresfinanzbericht vom 01.01.2022 bis zum 30.06.2022
Report Publication Announcement Classification · 100% confidence The document is a short notification (under 1,000 characters) that serves as a formal announcement regarding the availability of a half-year financial report. It provides a link to the report and specifies the publication date. Per the 'Menu vs Meal' rule, since this is an announcement of a report rather than the report itself, it is classified as a Report Publication Announcement (RPA).
2022-08-17 German
Hinweis auf Halbjahresfinanzbericht vom 01.01.2022 bis zum 30.06.2022
Report Publication Announcement Classification · 99% confidence The document text is very short (798 characters) and explicitly serves as a 'Hinweis' (Notice) regarding the availability of a 'Halbjahresfinanzbericht' (Half-Year Financial Report) for the period 01.01.2022 to 30.06.2022. It provides a link where the actual report can be found and states the publication date (25.08.2022). According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement pointing to the full report constitutes a Report Publication Announcement (RPA), not the comprehensive Interim Report (IR) itself. The classification should be RPA.
2022-08-17 German
Konzernabschluss zum Geschäftsjahr vom 01.01.2021 bis zum 31.12.2021
Annual Report (ESEF) Classification · 100% confidence FY 2021
2022-05-10 German
Ergänzt am 27.09.2022
Audit Report / Information Classification · 98% confidence The document text contains the title "JAHRESABSCHLUSS ZUM 31. DEZEMBER 2021" (Annual Financial Statements as of December 31, 2021) and explicitly mentions "Zusammengefasster Konzernlagebericht des Vorstands 2021" (Condensed Group Management Report 2021). This content structure, focusing on the full year's performance, segment breakdown (Generika, Consumer Healthcare, Spezialpharmazeutika), detailed financial metrics (Umsatz, EBITDA), and strategic review for the entire fiscal year, is characteristic of a comprehensive annual report. Although the title mentions 'Konzernlagebericht' (Management Report), the context of being part of the 'Jahresabschluss' (Annual Financial Statements) and the extensive detail provided strongly suggests this is the core Annual Report document, which in the US context is equivalent to a 10-K, or in this German context, the primary annual filing. Given the options, '10-K' is the closest equivalent for a comprehensive annual report covering full financial performance and management discussion for the year ending December 31, 2021. It is not a short announcement (RPA/RNS), nor is it just an interim report (IR). FY 2021
2022-04-12 German
Report Publication Announcement 2022
Report Publication Announcement Classification · 100% confidence The document is titled "Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG". It explicitly states that STADA Arzneimittel AG is announcing *when* and *where* the Annual financial report of the group will be disclosed (March 22, 2022), providing links to the future location of the report. Since the document itself is an announcement about the publication of a report, and not the full report (10-K or IR), it fits the definition of a Report Publication Announcement (RPA). The document length (1714 chars) is short, supporting the 'announcement' classification over the actual report classification.
2022-03-14 English
Report Publication Announcement 2022
Report Publication Announcement Classification · 100% confidence The document is a short announcement dated March 14, 2022, titled "Preliminary announcement of the publication of financial reports." It explicitly states that the company (STADA Arzneimittel AG) is announcing *when* and *where* the Annual financial report for FY2021 will be disclosed (March 22, 2022), providing links to the future location of the reports. According to Rule #2 (The 'MENU VS MEAL' Rule), a short document announcing the publication of a report, rather than containing the full report content, should be classified as a Report Publication Announcement (RPA).
2022-03-14 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.